ClinicalTrials.Veeva

Menu

Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients

N

National Institute of Cardiology, Laranjeiras, Brazil

Status and phase

Enrolling
Early Phase 1

Conditions

Microvascular Function
Resistant Hypertension
Arterial Hypertension
Nitrate Supplementation

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Beetroot extract

Study type

Interventional

Funder types

Other

Identifiers

NCT06169241
70847523.9.0000.5272

Details and patient eligibility

About

Arterial hypertension (AH) has been identified as an important public health problem and considered a new epidemic with high mortality and morbidity. High blood pressure (BP) levels increase the chances of coronary artery disease (CAD), heart failure (HF), stroke, chronic renal failure (CRF) and death. Beetroot powder may be an easier way to increase the availability of nitric oxide and consequently vasodilation in these patients. However, studies are needed to evaluate its benefits in patients with AH.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Resistant hypertension, with a diagnosis described in the medical record, without changing medications or increasing doses in the last 30 days.

Exclusion criteria

  • neoplasms
  • heart failure
  • use of medications with nitrate in their formula
  • patients undergoing renal denervation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

50 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
The placebo group will be administered as a colored and flavored isocaloric supplement composed of maltodextrin.
Treatment:
Dietary Supplement: Placebo
Beetroot extract
Active Comparator group
Description:
Beetroot extract powder supplementation with 400mg of nitrate per dose in the amount of 10g per day orally will be used in the group.
Treatment:
Dietary Supplement: Beetroot extract

Trial contacts and locations

1

Loading...

Central trial contact

EDUARDO TIBIRICA, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems